Butea monosperma (Lam.) Taub.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | B. frondosa Koenig ex Roxb. |
| Family | Papilionaceae; Fabaceae. |
| Habitat | Throughout India, up to 1,200 m except in very arid regions. |
| English | Flame of the Forest, Butea Gum, Bengal Kino. |
| Ayurvedic | Paalasha, Kimshuka, Raktapushpaka, Kshaarshreshtha, Brahmavriksha, Samidvar. |
| Unani | Dhaak, Samagh Dhaak, Kamarkas. |
| Siddha / Tamil | Palasam, Purasus. |
| Folk | Tesu. |
| Action | Bark—astringent, styptic (prescribed in bleeding piles, ulcers, haemorrhages, menstrual disorders), anthelmintic. Flowers— astringent, diuretic, emmenagogue (also given for leucorrhoea). A decoction of flowers is given in diarrhoea and haematuria, also to puerperal women. Seeds—clinical use of seeds as an anthelmintic drug is not considered safe in humans. |
| Dosage | Stem bark—5–10 g powder (API Vol. II); flower—3–6 g powder; seed—3 g powder; gum—0.5–1.5 g (API Vol. IV.) |
| Taxonomic Cohort | Genus Butea (2 documented species); Family Papilionaceae (67 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Butea monosperma (taxonomically cited with authority (Lam.) Taub.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Papilionaceae; Fabaceae (primary family classification: Papilionaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy B. frondosa Koenig ex Roxb, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Throughout India, up to 1,200 m except in very arid regions.
Across classical and vernacular Indian systems of medicine, Butea monosperma is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Flame of the Forest, Butea Gum, Bengal Kino; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Paalasha, Kimshuka, Raktapushpaka, Kshaarshreshtha, Brahmavriksha, Samidvar; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Dhaak, Samagh Dhaak, Kamarkas; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Palasam, Purasus; in regional Indian folk and vernacular ethnobotany as Tesu. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Butea monosperma are: Bark—astringent, styptic (prescribed in bleeding piles, ulcers, haemorrhages, menstrual disorders), anthelmintic. Flowers— astringent, diuretic, emmenagogue (also given for leucorrhoea). A decoction of flowers is given in diarrhoea and haematuria, also to puerperal women. Seeds—clinical use of seeds as an anthelmintic drug is not considered safe in humans. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Butea monosperma establish the following evidence base: Leaves—antibacterial. Stem bark— antifungal. An aqueous extract of flowers has shown hepatoprotective activity against CCl4-induced liver injury in albino rats. Extracts of flowers have exhibited significant anti-oestrogenic activity in mice. The seed suspension, on oral administration to albino rats (175 and 350 mg/kg body weight), showed 38.46 and 68.75% cases, respectively, where pregnancy was not interrupted but foetus was malformed. Alcoholic extract of the whole plant produced persistent vasodepression in cats. The plant contains flavonoids and glucosides—butin, butrin, isobutrin and palastrin. Flowers contain butrin, coreopsin, monospermoside and their derivatives and sulphurein; also chalcones.
In specialized pharmacognostic classifications, Butea monosperma is also represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Butea monosperma flower.

Figure 2: Authenticated crude herb specimen — Butea monosperma gum.

Botanical Reference 1: Butea monosperma — Botanical specimen

Botanical Reference 2: Butea monosperma — Botanical specimen

Botanical Reference 3: Butea monosperma — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Butea comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Butea superba (Action: Seeds—sedative and anthelmintic; decoction emollient and used topically for…). Comparing Butea monosperma alongside its congeners in genus Butea highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Papilionaceae encompasses 67 documented medicinal species (3.69% of the 1,814-species flora). Other representative medicinal members of Papilionaceae include: Abrus precatorius Linn. (Gunjaa), Alhagi pseudalhagi (Yavaasaka), Arachis hypogaea (Mandapi), Atylosia goensis (Maashaparni), Cajanus cajan (Aadhaki). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 3: Quantitative documentation profile across all 67 medicinal species of family Papilionaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Butea monosperma are prescribed as follows: Stem bark—5–10 g powder (API Vol. II); flower—3–6 g powder; seed—3 g powder; gum—0.5–1.5 g (API Vol. IV.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Butea monosperma integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.